Chargement en cours...
Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies
The treatment landscape for patients with advanced non-small cell lung cancer has evolved greatly with the advent of immune checkpoint inhibitors. However, many patients do not derive benefit from checkpoint blockade, developing either primary or secondary resistance, highlighting a need for alterna...
Enregistré dans:
| Publié dans: | Ther Adv Med Oncol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7339077/ https://ncbi.nlm.nih.gov/pubmed/32670423 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920937902 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|